Ceapro Inc V.CZO

Volume 131,400 in Canada

[prophetoffactz]

Someone wanted off the bus. With $13 million cash and no debt, a profitable base business set to potentially accelerate with Symrise, Health Canada approval for a Phase I/IIa clinical trial targeting large markets, PGX moving towards commercial production after bioavailability testing, and the fibrosis opportunity CZO is absurdly, absurdly cheap.

[Alex1726]

Cheap you say , maybe , and what if any pipeline never go throw any commercial development?

[laurencelefou]

Companies working on drug or nutraceutical development can never be sure that their formulation will become a commercial success.  Investors must consider that possibility when deciding on whether or not to invest in a company with a pipeline that may or may not become a profitable venture.  If one of Ceapro’s potential formulation is successfully marketed, then the share price will

[prophetoffactz]

TTM Operating Cash flows (OCF) $6,317,000 TTM cash flow yield / Enterprise Value 16.1% That's cheap! "Companies working on drug or nutraceutical development can never be sure that their formulation will become a commercial success." The thing about CZO is the yeast beta glucan market already exists. It may be more of a manufacturing scale-up

[prophetoffactz]

I don't have a total including yesterday but it may be a single holders at RBC behind a lot of the selling. Recent Trades - Last 10 of 17 Time ET Ex Price Change Volume Buyer Seller Markers 10:12:12 O 0.60   500 1 Anonymous 2 RBC

[fossi_2002]

Again today RBC is the seller, on the other side Anonymus (that's me in this case) is the buyer. This is certainly about year-end prices. The positive future possibilities have been mentioned here several times by Proph and Lauren. On the other hand, it has to be seen that the overall market might remain negative and Ceapro could show lower profits due to higher costs for research and

[Hopeforthebest]

I mainly raise the concern on the amount of trades and subsequently volume. Having no trades to maybe less than 10 trades per day is an indicator of no one being interested in the stock.  Continual missing deadlines, lack of communications, 1 one skew product line potential of lower profits does not attract  investors to invest but drives them away, which the golden phallus has done

[Alex1726]

And if as you say absurdly cheap then you might have bought a lot of shares today. I do think that you own no shares. You're only here to pump it up.

[prophetoffactz]

131,400 shares traded in Canada yesterday. 101,900 shares traded today. That's 233,300 in Canada in two days. It will be good to clear and sellers. CZO is now going into its two strongest quarters(Q1, Q2) with the Canadian dollar down about 7% from where it started last year. Symrise will be placing its orders one year into a deal anticipating acceleration. CZO has been doing presentation